2 completed, 1 unknown. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Lisuride: new trials by email Literature Review of Lisuride trials Research Report on Lisuride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist Safinamide (as add-on therapy) - Idiopathic Parkinson's Disease | Phase 3 | Completed | Newron Pharmaceuticals SPA | 679 | 2007-11-01 | 2013-10-29 |
| Infusion Laboratory: Protocol 2 (Lisuride) - 3 Lisuride - Cocaine-Related Disorders | Phase 1 | Unknown | National Institute on Drug Abuse (NIDA) | 2 | 1996-03-01 | 2017-01-11 |
| Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) Lisuride, Ropinirole, Placebo - Restless Legs Syndrome | Phase 3 | Completed | Axxonis Pharma AG | 300 | 2012-03-07 |
Cocaine-Related Disorders (1) · Parkinson Disease (1) · Restless Legs Syndrome (1)
Axxonis Pharma AG (1) · National Institute on Drug Abuse (NIDA) (1) · Newron Pharmaceuticals SPA (1)
Germany (2) · United States (2) · Argentina (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · Colombia (1) · Croatia (1) · Czechia (1) · Finland (1) · India (1) · Italy (1) · Mexico (1) · Peru (1)
Heike Benes, MD (1) · Jonathan Willmer, MD (1) · Walter Ling, M.D. (1)